Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Director departure
Appointed director
|
|
ADOLOR CORP (ADLR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/10/2011 |
8-K
| Form 8-K - Current report |
| 07/27/2011 |
8-K
| Quarterly results |
| 04/28/2011 |
8-K
| Form 8-K - Current report |
| 10/28/2010 |
8-K
| Form 8-K - Current report |
| 07/29/2010 |
8-K
| Form 8-K - Current report |
| 04/28/2010 |
8-K
| Quarterly results|
Docs:
|
"ADOLOR CORPORATION REPORTS FIRST QUARTER 2010 FINANCIAL RESULTS EXTON, PA, April 28, 2010 — Adolor Corporation today reported a net loss of $9.6 million, or $ per basic and diluted share, for the three months ended March 31, 2010, compared to a net loss of $13.2 million, or $ per basic and diluted share, for the three months ended March 31, 2009. Net product sales of ENTEREG® for the three months ended March 31, 2010 were $5.3 million compared to $1.4 million for the three months ended March 31, 2009, primarily as a result of growth in the number of ordering hospitals and increased usage at ordering hospitals. Net product sales for the three months ended March 31, 2010 were recognized at the time of shipment as compared to net product sales for the three months ended March 31, 2009, which ..." |
|
| 10/29/2009 |
8-K
| Form 8-K - Current report |
| 07/29/2009 |
8-K
| Form 8-K - Current report |
| 04/29/2009 |
8-K
| Form 8-K -- Current report |
| 02/25/2009 |
8-K
| Form 8-K -- Current report |
| 10/28/2008 |
8-K
| Quarterly results |
| 08/06/2008 |
8-K
| Quarterly results |
| 04/28/2008 |
8-K
| Quarterly results |
| 02/29/2008 |
8-K
| Quarterly results |
| 10/31/2007 |
8-K
| Quarterly results |
| 07/30/2007 |
8-K
| Quarterly results |
| 05/03/2007 |
8-K
| Quarterly results |
| 02/27/2007 |
8-K
| Quarterly results |
| 10/31/2006 |
8-K
| Quarterly results |
| 07/31/2006 |
8-K
| Quarterly results |
|
|